BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7396542)

  • 1. Mechlorethamine hydrochloride solutions and ointment. Prolonged stability and biological activity.
    Taylor JR; Halprin KM; Levine V; Aoyagi T
    Arch Dermatol; 1980 Jul; 116(7):783-5. PubMed ID: 7396542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of the nitrogen mustard mechlorethamine in novel formulations for dermatological use.
    Ritschel WA; Ye W; Buhse L; Reepmeyer JC
    Int J Pharm; 2008 Oct; 362(1-2):67-73. PubMed ID: 18634862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of mycosis fungoides with ointment-based mechlorethamine.
    Price NM; Deneau DG; Hoppe RT
    Arch Dermatol; 1982 Apr; 118(4):234-7. PubMed ID: 7065680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long term stability of mechlorethamine hydrochloride (nitrogen mustard) ointment measured by HPLC.
    Cummings J; MacLellan A; Langdon SJ; Smyth JF
    J Pharm Pharmacol; 1993 Jan; 45(1):6-9. PubMed ID: 8094449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical mechlorethamine in the treatment of mycosis fungoides. Uniformity of application and potential for environmental contamination.
    Breneman DL; Nartker AL; Ballman EA; Pruemer JM; Blumsack RF; Davis M; Breneman JC
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 1):1059-64. PubMed ID: 1844356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ointment-based mechlorethamine treatment for mycosis fungoides.
    Price NM; Hoppe RT; Deneau DG
    Cancer; 1983 Dec; 52(12):2214-9. PubMed ID: 6640491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
    de Quatrebarbes J; Estève E; Bagot M; Bernard P; Beylot-Barry M; Delaunay M; D'Incan M; Souteyrand P; Vaillant L; Cordel N; Courville P; Joly P
    Arch Dermatol; 2005 Sep; 141(9):1117-20. PubMed ID: 16172308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topically applied mechlorethamine in the treatment of psoriasis.
    Mandy S; Taylor JR; Halprin K
    Arch Dermatol; 1971 Mar; 103(3):272-6. PubMed ID: 5548274
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of topical mechlorethamine on skin lesions of psoriasis.
    Epstein E; Ugel AR
    Arch Dermatol; 1970 Nov; 102(5):504-6. PubMed ID: 5474112
    [No Abstract]   [Full Text] [Related]  

  • 10. Stability of chlortetracycline hydrochloride and chloramphenicol in some ophthalmic ointment bases.
    Attia MA; el-Sourady HA; el-Shanawany SM
    Pharmazie; 1985 Sep; 40(9):629-31. PubMed ID: 4070345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical and chemical stability of pemetrexed in infusion solutions.
    Zhang Y; Trissel LA
    Ann Pharmacother; 2006 Jun; 40(6):1082-5. PubMed ID: 16720706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of mechlorethamine hydrochloride 0.01% ointment in aquaphor base.
    Zhang Y; Trissel LA; Johansen JF; Kimball CL
    Int J Pharm Compd; 1998; 2(1):89-91. PubMed ID: 23989487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis.
    Thiers BH
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S69-71. PubMed ID: 9344189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical mustine hydrochloride and psoriasis.
    Purdy MJ
    Australas J Dermatol; 1973 Aug; 14(2):68-72. PubMed ID: 4759451
    [No Abstract]   [Full Text] [Related]  

  • 16. [Local Caryolysine].
    Avril MF
    Ann Dermatol Venereol; 1987; 114(1):133-41. PubMed ID: 3579129
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies of quality and stability of mass-produced and for storage intended ointments. IV. Less stable ointments].
    Sarsúnová M; Gremenová B; Lukácová O; Rimanová E; Hudáková G
    Cesk Farm; 1974 Mar; 23(2):65-9. PubMed ID: 4821798
    [No Abstract]   [Full Text] [Related]  

  • 18. Tacrolimus ointment for the treatment of severe facial plaque psoriasis.
    Kroft EB; Erceg A; Maimets K; Vissers W; van der Valk PG; van de Kerkhof PC
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):249-51. PubMed ID: 15752305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of psoriasis with calcipotriol used as monotherapy.
    Ramsay CA
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S53-4. PubMed ID: 9344185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical therapy of psoriasis with mechlorethamine.
    Zackheim HS; Arnold JE; Farber EM; Cox AJ
    Arch Dermatol; 1972 May; 105(5):702-6. PubMed ID: 5026678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.